lrbesartan - Global and China Top Players Market Share and Ranking 2024
Irbesartan is used to treat high blood pressure (hypertension) and to help protect the kidneys from damage due to diabetes. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Irbesartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). It works by relaxing blood vessels so that blood can flow more easily.
This report studies and analyses global lrbesartan status and future trends, helps the client to determine the lrbesartan market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for lrbesartan, and provides market size (in Tons & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global lrbesartan market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (Tons)
(2) Global lrbesartan sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (Tons)
(3) China lrbesartan sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (Tons)
(4) Global lrbesartan key consuming regions, consumption quantity, consumption value and demand structure
(5) Global lrbesartan key producing regions, capacity, production, and year over year growth
(6) lrbesartan industry chains, upstream, midstream and downstream
According to latest study, the global market for lrbesartan should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China lrbesartan market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States lrbesartan market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Research Institute grew percent to account for percent of the total market sales, and Pharmaceutical grew percent.
Market segment by players, this report covers
Euroapi
Tenatra Chemie
Jai Radhe Sales
Dr. Reddy's Laboratories
Sanofi
Octavius Pharma
Teva
Piramal Group
Zydus Lifesciences
Macleods Pharmaceuticals
Cipla
Siegfried AG
Aurobindo
Alembic Pharmaceuticals
MSN Laboratories
Calyx Chemicals and Pharmaceuticals
Divis Laboratories
Mylan
Hetero Drugs
Apeloa Pharmaceutical
Market segment by Type, covers
Purity ≥ 98 %
Purity ≥ 99 %
Market segment by Application, can be divided into
Research Institute
Pharmaceutical
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe lrbesartan product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global lrbesartan market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China lrbesartan market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of lrbesartan, percent & CAGR, 2018-2029
Chapter 5: lrbesartan industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 lrbesartan Definition
1.2 Global lrbesartan Market Size and Forecast
1.2.1 By Consumption Value, Global lrbesartan Market Size，2018-2029
1.2.2 By Sales Quantity, Global lrbesartan Market Size，2018-2029
1.2.3 Global lrbesartan Average Selling Price (ASP)，2018-2029
1.3 China lrbesartan Market Size and Forecast
1.3.1 By Consumption Value, China lrbesartan Market Size，2018-2029
1.3.2 By Sales Quantity, China lrbesartan Market Size，2018-2029
1.3.3 China lrbesartan Average Selling Price (ASP)， 2018-2029
1.4 Share of China lrbesartan Market with Respect to the Global Market
1.4.1 By Consumption Value, China lrbesartan Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China lrbesartan Market Share in Global, 2018-2029
1.4.3 lrbesartan Market Size: China VS Global, 2018-2029
1.5 lrbesartan Market Dynamics
1.5.1 lrbesartan Market Drivers
1.5.2 lrbesartan Market Restraints
1.5.3 lrbesartan Industry Trends
1.5.4 lrbesartan Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of lrbesartan, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of lrbesartan, Global Market Share by Company, 2018-2023
2.3 lrbesartan Average Selling Price (ASP) by Company, 2018-2023
2.4 Global lrbesartan Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global lrbesartan Concentration Ratio
2.6 Global lrbesartan Mergers & Acquisitions, Expansion Plans
2.7 Global lrbesartan Manufacturers Product Type
2.8 Head Office and lrbesartan Production Site of Key Manufacturer
2.9 lrbesartan Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of lrbesartan, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of lrbesartan, China Market Share by Company, 2018-2023
3.3 China lrbesartan Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global lrbesartan Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global lrbesartan Capacity by Region
4.3 Global lrbesartan Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global lrbesartan Production by Region, 2018-2029
4.5 Global lrbesartan Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 lrbesartan Industry Chain
5.2 lrbesartan Upstream Analysis
5.2.1 lrbesartan Core Raw Materials
5.2.2 Main Manufacturers of lrbesartan Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 lrbesartan Production Mode
5.6 lrbesartan Procurement Model
5.7 lrbesartan Industry Sales Model and Sales Channels
5.7.1 lrbesartan Sales Model
5.7.2 lrbesartan Typical Distributors
6 Sights by Type
6.1 lrbesartan Classification
6.1.1 Purity ≥ 98 %
6.1.2 Purity ≥ 99 %
6.2 By Type, Global lrbesartan Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global lrbesartan Consumption Value, 2018-2029
6.4 By Type, Global lrbesartan Sales Quantity, 2018-2029
6.5 By Type, Global lrbesartan Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 lrbesartan Segment by Application
7.1.1 Research Institute
7.1.2 Pharmaceutical
7.1.3 Others
7.2 By Application, Global lrbesartan Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global lrbesartan Consumption Value, 2018-2029
7.4 By Application, Global lrbesartan Sales Quantity, 2018-2029
7.5 By Application, Global lrbesartan Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global lrbesartan Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global lrbesartan Consumption Value, 2018-2029
8.3 By Region, Global lrbesartan Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America lrbesartan & Forecasts, 2018-2029
8.4.2 By Country, North America lrbesartan Market Size Market Share
8.5 Europe
8.5.1 Europe lrbesartan Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe lrbesartan Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific lrbesartan Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific lrbesartan Market Size Market Share
8.7 South America
8.7.1 South America lrbesartan Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America lrbesartan Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global lrbesartan Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global lrbesartan Consumption Value, 2018-2029
9.3 By Country, Global lrbesartan Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. lrbesartan Market Size, 2018-2029
9.4.2 By Type, U.S. lrbesartan Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. lrbesartan Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe lrbesartan Market Size, 2018-2029
9.5.2 By Type, Europe lrbesartan Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe lrbesartan Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China lrbesartan Market Size, 2018-2029
9.6.2 By Type, China lrbesartan Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China lrbesartan Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan lrbesartan Market Size, 2018-2029
9.7.2 By Type, Japan lrbesartan Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan lrbesartan Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea lrbesartan Market Size, 2018-2029
9.8.2 By Type, South Korea lrbesartan Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea lrbesartan Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia lrbesartan Market Size, 2018-2029
9.9.2 By Type, Southeast Asia lrbesartan Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia lrbesartan Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India lrbesartan Market Size, 2018-2029
9.10.2 By Type, India lrbesartan Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India lrbesartan Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa lrbesartan Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa lrbesartan Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa lrbesartan Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Euroapi
10.1.1 Euroapi Company Information, Head Office, Market Area, and Industry Position
10.1.2 Euroapi lrbesartan Models, Specifications, and Application
10.1.3 Euroapi lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Euroapi Company Profile and Main Business
10.1.5 Euroapi Recent Developments
10.2 Tenatra Chemie
10.2.1 Tenatra Chemie Company Information, Head Office, Market Area, and Industry Position
10.2.2 Tenatra Chemie lrbesartan Models, Specifications, and Application
10.2.3 Tenatra Chemie lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Tenatra Chemie Company Profile and Main Business
10.2.5 Tenatra Chemie Recent Developments
10.3 Jai Radhe Sales
10.3.1 Jai Radhe Sales Company Information, Head Office, Market Area, and Industry Position
10.3.2 Jai Radhe Sales lrbesartan Models, Specifications, and Application
10.3.3 Jai Radhe Sales lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Jai Radhe Sales Company Profile and Main Business
10.3.5 Jai Radhe Sales Recent Developments
10.4 Dr. Reddy's Laboratories
10.4.1 Dr. Reddy's Laboratories Company Information, Head Office, Market Area, and Industry Position
10.4.2 Dr. Reddy's Laboratories lrbesartan Models, Specifications, and Application
10.4.3 Dr. Reddy's Laboratories lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Dr. Reddy's Laboratories Company Profile and Main Business
10.4.5 Dr. Reddy's Laboratories Recent Developments
10.5 Sanofi
10.5.1 Sanofi Company Information, Head Office, Market Area, and Industry Position
10.5.2 Sanofi lrbesartan Models, Specifications, and Application
10.5.3 Sanofi lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Sanofi Company Profile and Main Business
10.5.5 Sanofi Recent Developments
10.6 Octavius Pharma
10.6.1 Octavius Pharma Company Information, Head Office, Market Area, and Industry Position
10.6.2 Octavius Pharma lrbesartan Models, Specifications, and Application
10.6.3 Octavius Pharma lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Octavius Pharma Company Profile and Main Business
10.6.5 Octavius Pharma Recent Developments
10.7 Teva
10.7.1 Teva Company Information, Head Office, Market Area, and Industry Position
10.7.2 Teva lrbesartan Models, Specifications, and Application
10.7.3 Teva lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Teva Company Profile and Main Business
10.7.5 Teva Recent Developments
10.8 Piramal Group
10.8.1 Piramal Group Company Information, Head Office, Market Area, and Industry Position
10.8.2 Piramal Group lrbesartan Models, Specifications, and Application
10.8.3 Piramal Group lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Piramal Group Company Profile and Main Business
10.8.5 Piramal Group Recent Developments
10.9 Zydus Lifesciences
10.9.1 Zydus Lifesciences Company Information, Head Office, Market Area, and Industry Position
10.9.2 Zydus Lifesciences lrbesartan Models, Specifications, and Application
10.9.3 Zydus Lifesciences lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Zydus Lifesciences Company Profile and Main Business
10.9.5 Zydus Lifesciences Recent Developments
10.10 Macleods Pharmaceuticals
10.10.1 Macleods Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.10.2 Macleods Pharmaceuticals lrbesartan Models, Specifications, and Application
10.10.3 Macleods Pharmaceuticals lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Macleods Pharmaceuticals Company Profile and Main Business
10.10.5 Macleods Pharmaceuticals Recent Developments
10.11 Cipla
10.11.1 Cipla Company Information, Head Office, Market Area, and Industry Position
10.11.2 Cipla lrbesartan Models, Specifications, and Application
10.11.3 Cipla lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Cipla Company Profile and Main Business
10.11.5 Cipla Recent Developments
10.12 Siegfried AG
10.12.1 Siegfried AG Company Information, Head Office, Market Area, and Industry Position
10.12.2 Siegfried AG lrbesartan Models, Specifications, and Application
10.12.3 Siegfried AG lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Siegfried AG Company Profile and Main Business
10.12.5 Siegfried AG Recent Developments
10.13 Aurobindo
10.13.1 Aurobindo Company Information, Head Office, Market Area, and Industry Position
10.13.2 Aurobindo lrbesartan Models, Specifications, and Application
10.13.3 Aurobindo lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Aurobindo Company Profile and Main Business
10.13.5 Aurobindo Recent Developments
10.14 Alembic Pharmaceuticals
10.14.1 Alembic Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.14.2 Alembic Pharmaceuticals lrbesartan Models, Specifications, and Application
10.14.3 Alembic Pharmaceuticals lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Alembic Pharmaceuticals Company Profile and Main Business
10.14.5 Alembic Pharmaceuticals Recent Developments
10.15 MSN Laboratories
10.15.1 MSN Laboratories Company Information, Head Office, Market Area, and Industry Position
10.15.2 MSN Laboratories lrbesartan Models, Specifications, and Application
10.15.3 MSN Laboratories lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.15.4 MSN Laboratories Company Profile and Main Business
10.15.5 MSN Laboratories Recent Developments
10.16 Calyx Chemicals and Pharmaceuticals
10.16.1 Calyx Chemicals and Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.16.2 Calyx Chemicals and Pharmaceuticals lrbesartan Models, Specifications, and Application
10.16.3 Calyx Chemicals and Pharmaceuticals lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.16.4 Calyx Chemicals and Pharmaceuticals Company Profile and Main Business
10.16.5 Calyx Chemicals and Pharmaceuticals Recent Developments
10.17 Divis Laboratories
10.17.1 Divis Laboratories Company Information, Head Office, Market Area, and Industry Position
10.17.2 Divis Laboratories lrbesartan Models, Specifications, and Application
10.17.3 Divis Laboratories lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.17.4 Divis Laboratories Company Profile and Main Business
10.17.5 Divis Laboratories Recent Developments
10.18 Mylan
10.18.1 Mylan Company Information, Head Office, Market Area, and Industry Position
10.18.2 Mylan lrbesartan Models, Specifications, and Application
10.18.3 Mylan lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.18.4 Mylan Company Profile and Main Business
10.18.5 Mylan Recent Developments
10.19 Hetero Drugs
10.19.1 Hetero Drugs Company Information, Head Office, Market Area, and Industry Position
10.19.2 Hetero Drugs lrbesartan Models, Specifications, and Application
10.19.3 Hetero Drugs lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.19.4 Hetero Drugs Company Profile and Main Business
10.19.5 Hetero Drugs Recent Developments
10.20 Apeloa Pharmaceutical
10.20.1 Apeloa Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.20.2 Apeloa Pharmaceutical lrbesartan Models, Specifications, and Application
10.20.3 Apeloa Pharmaceutical lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.20.4 Apeloa Pharmaceutical Company Profile and Main Business
10.20.5 Apeloa Pharmaceutical Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. lrbesartan Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. lrbesartan Market Restraints
Table 3. lrbesartan Market Trends
Table 4. lrbesartan Industry Policy
Table 5. Global lrbesartan Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global lrbesartan Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global lrbesartan Sales Quantity by Company, (2018-2023) & (Tons), Ranked Based on Sales in 2022
Table 8. Global lrbesartan Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global lrbesartan Average Selling Price (ASP) by Company, (2018-2023) & (US$/Ton)
Table 10. Global lrbesartan Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global lrbesartan Mergers & Acquisitions, Expansion Plans
Table 12. Global lrbesartan Manufacturers Product Type
Table 13. Head Office and lrbesartan Production Site of Key Manufacturer
Table 14. lrbesartan Capacity of Major Manufacturers and Future Plan
Table 15. China lrbesartan Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China lrbesartan Sales Quantity by Company, (2018-2023) & (Tons), Ranked Based on Sales in 2022
Table 17. China lrbesartan Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global lrbesartan Production & Forecast by Region, 2018 VS 2022 VS 2029, (Tons)
Table 19. Global lrbesartan Production by Region, 2018-2023, (Tons)
Table 20. Global lrbesartan Production Forecast by Region, 2024-2029, (Tons)
Table 21. Global Key Players of lrbesartan Upstream (Raw Materials)
Table 22. Global lrbesartan Typical Customers
Table 23. lrbesartan Typical Distributors
Table 24. By Type, Global lrbesartan Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global lrbesartan Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global lrbesartan Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global lrbesartan Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global lrbesartan Sales Quantity, 2018-2029, (Tons)
Table 29. By Country, Global lrbesartan Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global lrbesartan Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global lrbesartan Consumption Value Market Share, 2018-2029
Table 32. By Country, Global lrbesartan Sales Quantity, 2018-2029, (Tons)
Table 33. By Country, Global lrbesartan Sales Quantity Market Share, 2018-2029
Table 34. Euroapi Company Information, Head Office, Market Area, and Industry Position
Table 35. Euroapi lrbesartan Models, Specifications, and Application
Table 36. Euroapi lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 37. Euroapi Company Profile and Main Business
Table 38. Euroapi Recent Developments
Table 39. Tenatra Chemie Company Information, Head Office, Market Area, and Industry Position
Table 40. Tenatra Chemie lrbesartan Models, Specifications, and Application
Table 41. Tenatra Chemie lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 42. Tenatra Chemie Company Profile and Main Business
Table 43. Tenatra Chemie Recent Developments
Table 44. Jai Radhe Sales Company Information, Head Office, Market Area, and Industry Position
Table 45. Jai Radhe Sales lrbesartan Models, Specifications, and Application
Table 46. Jai Radhe Sales lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 47. Jai Radhe Sales Company Profile and Main Business
Table 48. Jai Radhe Sales Recent Developments
Table 49. Dr. Reddy's Laboratories Company Information, Head Office, Market Area, and Industry Position
Table 50. Dr. Reddy's Laboratories lrbesartan Models, Specifications, and Application
Table 51. Dr. Reddy's Laboratories lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 52. Dr. Reddy's Laboratories Company Profile and Main Business
Table 53. Dr. Reddy's Laboratories Recent Developments
Table 54. Sanofi Company Information, Head Office, Market Area, and Industry Position
Table 55. Sanofi lrbesartan Models, Specifications, and Application
Table 56. Sanofi lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 57. Sanofi Company Profile and Main Business
Table 58. Sanofi Recent Developments
Table 59. Octavius Pharma Company Information, Head Office, Market Area, and Industry Position
Table 60. Octavius Pharma lrbesartan Models, Specifications, and Application
Table 61. Octavius Pharma lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 62. Octavius Pharma Company Profile and Main Business
Table 63. Octavius Pharma Recent Developments
Table 64. Teva Company Information, Head Office, Market Area, and Industry Position
Table 65. Teva lrbesartan Models, Specifications, and Application
Table 66. Teva lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 67. Teva Company Profile and Main Business
Table 68. Teva Recent Developments
Table 69. Piramal Group Company Information, Head Office, Market Area, and Industry Position
Table 70. Piramal Group lrbesartan Models, Specifications, and Application
Table 71. Piramal Group lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 72. Piramal Group Company Profile and Main Business
Table 73. Piramal Group Recent Developments
Table 74. Zydus Lifesciences Company Information, Head Office, Market Area, and Industry Position
Table 75. Zydus Lifesciences lrbesartan Models, Specifications, and Application
Table 76. Zydus Lifesciences lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 77. Zydus Lifesciences Company Profile and Main Business
Table 78. Zydus Lifesciences Recent Developments
Table 79. Macleods Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 80. Macleods Pharmaceuticals lrbesartan Models, Specifications, and Application
Table 81. Macleods Pharmaceuticals lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 82. Macleods Pharmaceuticals Company Profile and Main Business
Table 83. Macleods Pharmaceuticals Recent Developments
Table 84. Cipla Company Information, Head Office, Market Area, and Industry Position
Table 85. Cipla lrbesartan Models, Specifications, and Application
Table 86. Cipla lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 87. Cipla Company Profile and Main Business
Table 88. Cipla Recent Developments
Table 89. Siegfried AG Company Information, Head Office, Market Area, and Industry Position
Table 90. Siegfried AG lrbesartan Models, Specifications, and Application
Table 91. Siegfried AG lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 92. Siegfried AG Company Profile and Main Business
Table 93. Siegfried AG Recent Developments
Table 94. Aurobindo Company Information, Head Office, Market Area, and Industry Position
Table 95. Aurobindo lrbesartan Models, Specifications, and Application
Table 96. Aurobindo lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 97. Aurobindo Company Profile and Main Business
Table 98. Aurobindo Recent Developments
Table 99. Alembic Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 100. Alembic Pharmaceuticals lrbesartan Models, Specifications, and Application
Table 101. Alembic Pharmaceuticals lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 102. Alembic Pharmaceuticals Company Profile and Main Business
Table 103. Alembic Pharmaceuticals Recent Developments
Table 104. MSN Laboratories Company Information, Head Office, Market Area, and Industry Position
Table 105. MSN Laboratories lrbesartan Models, Specifications, and Application
Table 106. MSN Laboratories lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 107. MSN Laboratories Company Profile and Main Business
Table 108. MSN Laboratories Recent Developments
Table 109. Calyx Chemicals and Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 110. Calyx Chemicals and Pharmaceuticals lrbesartan Models, Specifications, and Application
Table 111. Calyx Chemicals and Pharmaceuticals lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 112. Calyx Chemicals and Pharmaceuticals Company Profile and Main Business
Table 113. Calyx Chemicals and Pharmaceuticals Recent Developments
Table 114. Divis Laboratories Company Information, Head Office, Market Area, and Industry Position
Table 115. Divis Laboratories lrbesartan Models, Specifications, and Application
Table 116. Divis Laboratories lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 117. Divis Laboratories Company Profile and Main Business
Table 118. Divis Laboratories Recent Developments
Table 119. Mylan Company Information, Head Office, Market Area, and Industry Position
Table 120. Mylan lrbesartan Models, Specifications, and Application
Table 121. Mylan lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 122. Mylan Company Profile and Main Business
Table 123. Mylan Recent Developments
Table 124. Hetero Drugs Company Information, Head Office, Market Area, and Industry Position
Table 125. Hetero Drugs lrbesartan Models, Specifications, and Application
Table 126. Hetero Drugs lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 127. Hetero Drugs Company Profile and Main Business
Table 128. Hetero Drugs Recent Developments
Table 129. Apeloa Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 130. Apeloa Pharmaceutical lrbesartan Models, Specifications, and Application
Table 131. Apeloa Pharmaceutical lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 132. Apeloa Pharmaceutical Company Profile and Main Business
Table 133. Apeloa Pharmaceutical Recent Developments
List of Figures
Figure 1. lrbesartan Picture
Figure 2. Global lrbesartan Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global lrbesartan Sales Quantity, (Tons) & (2018-2029)
Figure 4. Global lrbesartan Average Selling Price (ASP), (2018-2029) & (US$/Ton)
Figure 5. China lrbesartan Consumption Value, (US$ million) & (2018-2029)
Figure 6. China lrbesartan Sales Quantity (Tons) & (2018-2029)
Figure 7. China lrbesartan Average Selling Price (ASP), (US$/Ton) & (2018-2029)
Figure 8. By Consumption Value, China lrbesartan Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China lrbesartan Market Share of Global, 2018-2029
Figure 10. Global lrbesartan Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China lrbesartan Key Participants, Market Share, 2022
Figure 12. Global lrbesartan Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global lrbesartan Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global lrbesartan Production Market Share & Forecast by Region, 2018-2029
Figure 15. lrbesartan Industry Chain
Figure 16. lrbesartan Procurement Model
Figure 17. lrbesartan Sales Model
Figure 18. lrbesartan Sales Channels, Direct Sales, and Distribution
Figure 19. Purity ≥ 98 %
Figure 20. Purity ≥ 99 %
Figure 21. By Type, Global lrbesartan Consumption Value, 2018-2029, US$ Million
Figure 22. By Type, Global lrbesartan Consumption Value Market Share, 2018-2029
Figure 23. By Type, Global lrbesartan Sales Quantity, 2018-2029, (Tons)
Figure 24. By Type, Global lrbesartan Sales Quantity Market Share, 2018-2029
Figure 25. By Type, Global lrbesartan Average Selling Price (ASP), 2018-2029, (US$/Ton)
Figure 26. Research Institute
Figure 27. Pharmaceutical
Figure 28. Others
Figure 29. By Application, Global lrbesartan Consumption Value, 2018-2029, US$ Million
Figure 30. By Application, Global lrbesartan Consumption Value Market Share, 2018-2029
Figure 31. By Application, Global lrbesartan Sales Quantity, 2018-2029, (Tons)
Figure 32. By Application, Global lrbesartan Sales Quantity Market Share, 2018-2029
Figure 33. By Application, Global lrbesartan Average Selling Price (ASP), 2018-2029, (US$/Ton)
Figure 34. By Region, Global lrbesartan Consumption Value Market Share, 2018-2029
Figure 35. By Region, Global lrbesartan Sales Quantity Market Share, 2018-2029
Figure 36. North America lrbesartan Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 37. By Country, North America lrbesartan Consumption Value Market Share, 2022
Figure 38. Europe lrbesartan Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 39. By Country, Europe lrbesartan Consumption Value Market Share, 2022
Figure 40. Asia Pacific lrbesartan Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country/Region, Asia Pacific lrbesartan Consumption Value Market Share, 2022
Figure 42. South America lrbesartan Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, South America lrbesartan Consumption Value Market Share, 2022
Figure 44. Middle East & Africa lrbesartan Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. U.S. lrbesartan Sales Quantity, 2018-2029, (Tons)
Figure 46. By Type, U.S. lrbesartan Sales Quantity Market Share, 2022 VS 2029
Figure 47. By Application, U.S. lrbesartan Sales Quantity Market Share, 2022 VS 2029
Figure 48. Europe lrbesartan Sales Quantity, 2018-2029, (Tons)
Figure 49. By Type, Europe lrbesartan Sales Quantity Market Share, 2022 VS 2029
Figure 50. By Application, Europe lrbesartan Sales Quantity Market Share, 2022 VS 2029
Figure 51. China lrbesartan Sales Quantity, 2018-2029, (Tons)
Figure 52. By Type, China lrbesartan Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, China lrbesartan Sales Quantity Market Share, 2022 VS 2029
Figure 54. Japan lrbesartan Sales Quantity, 2018-2029, (Tons)
Figure 55. By Type, Japan lrbesartan Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Application, Japan lrbesartan Sales Quantity Market Share, 2022 VS 2029
Figure 57. South Korea lrbesartan Sales Quantity, 2018-2029, (Tons)
Figure 58. By Type, South Korea lrbesartan Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Application, South Korea lrbesartan Sales Quantity Market Share, 2022 VS 2029
Figure 60. Southeast Asia lrbesartan Sales Quantity, 2018-2029, (Tons)
Figure 61. By Type, Southeast Asia lrbesartan Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Application, Southeast Asia lrbesartan Sales Quantity Market Share, 2022 VS 2029
Figure 63. India lrbesartan Sales Quantity, 2018-2029, (Tons)
Figure 64. By Type, India lrbesartan Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Application, India lrbesartan Sales Quantity Market Share, 2022 VS 2029
Figure 66. Middle East & Africa lrbesartan Sales Quantity, 2018-2029, (Tons)
Figure 67. By Type, Middle East & Africa lrbesartan Sales Quantity Market Share, 2022 VS 2029
Figure 68. By Application, Middle East & Africa lrbesartan Sales Quantity Market Share, 2022 VS 2029
Figure 69. Research Methodology
Figure 70. Breakdown of Primary Interviews
Figure 71. Bottom-up and Top-down Approaches
Figure 72. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|